BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34473647)

  • 1. AMPK mediates regulation of glomerular volume and podocyte survival.
    Banu K; Lin Q; Basgen JM; Planoutene M; Wei C; Reghuvaran AC; Tian X; Shi H; Garzon F; Garzia A; Chun N; Cumpelik A; Santeusanio AD; Zhang W; Das B; Salem F; Li L; Ishibe S; Cantley LG; Kaufman L; Lemley KV; Ni Z; He JC; Murphy B; Menon MC
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34473647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHROOM3-FYN Interaction Regulates Nephrin Phosphorylation and Affects Albuminuria in Allografts.
    Wei C; Banu K; Garzon F; Basgen JM; Philippe N; Yi Z; Liu R; Choudhuri J; Fribourg M; Liu T; Cumpelik A; Wong J; Khan M; Das B; Keung K; Salem F; Campbell KN; Kaufman L; Cravedi P; Zhang W; O'Connell PJ; He JC; Murphy B; Menon MC
    J Am Soc Nephrol; 2018 Nov; 29(11):2641-2657. PubMed ID: 30341149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
    Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
    Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
    Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y
    Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
    Agrawal V; Prasad N; Jain M; Pandey R
    Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression.
    Chen A; Feng Y; Lai H; Ju W; Li Z; Li Y; Wang A; Hong Q; Zhong F; Wei C; Fu J; Guan T; Liu B; Kretzler M; Lee K; He JC
    J Clin Invest; 2020 Oct; 130(10):5523-5535. PubMed ID: 32634130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy.
    Yang Y; Gubler MC; Beaufils H
    Nephron; 2002 Jul; 91(3):416-23. PubMed ID: 12119471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
    da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
    PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary podocytes in primary focal segmental glomerulosclerosis.
    Hara M; Yanagihara T; Kihara I
    Nephron; 2001 Nov; 89(3):342-7. PubMed ID: 11598401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.
    Morita M; Mii A; Shimizu A; Yasuda F; Shoji J; Masuda Y; Ohashi R; Nagahama K; Kaneko T; Tsuruoka S
    PLoS One; 2015; 10(4):e0116700. PubMed ID: 25875837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
    Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTOR-mediated podocyte hypertrophy regulates glomerular integrity in mice and humans.
    Puelles VG; van der Wolde JW; Wanner N; Scheppach MW; Cullen-McEwen LA; Bork T; Lindenmeyer MT; Gernhold L; Wong MN; Braun F; Cohen CD; Kett MM; Kuppe C; Kramann R; Saritas T; van Roeyen CR; Moeller MJ; Tribolet L; Rebello R; Sun YB; Li J; Müller-Newen G; Hughson MD; Hoy WE; Person F; Wiech T; Ricardo SD; Kerr PG; Denton KM; Furic L; Huber TB; Nikolic-Paterson DJ; Bertram JF
    JCI Insight; 2019 Sep; 4(18):. PubMed ID: 31534053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.
    Suzuki T; Matsusaka T; Nakayama M; Asano T; Watanabe T; Ichikawa I; Nagata M
    Am J Pathol; 2009 May; 174(5):1675-82. PubMed ID: 19359523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinculin is required to maintain glomerular barrier integrity.
    Lausecker F; Tian X; Inoue K; Wang Z; Pedigo CE; Hassan H; Liu C; Zimmer M; Jinno S; Huckle AL; Hamidi H; Ross RS; Zent R; Ballestrem C; Lennon R; Ishibe S
    Kidney Int; 2018 Mar; 93(3):643-655. PubMed ID: 29241625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
    Kistler AD; Singh G; Altintas MM; Yu H; Fernandez IC; Gu C; Wilson C; Srivastava SK; Dietrich A; Walz K; Kerjaschki D; Ruiz P; Dryer S; Sever S; Dinda AK; Faul C; Reiser J
    J Biol Chem; 2013 Dec; 288(51):36598-609. PubMed ID: 24194522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
    Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
    PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Glomerular Transcriptome Profiles of Adult-Onset Steroid Sensitive Focal Segmental Glomerulosclerosis and Minimal Change Disease.
    Tong J; Xie J; Ren H; Liu J; Zhang W; Wei C; Xu J; Zhang W; Li X; Wang W; Lv D; He JC; Chen N
    PLoS One; 2015; 10(11):e0140453. PubMed ID: 26536600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
    Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
    J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
    Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
    Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.